002007 華蘭生物
按盤價 
15.600 +0.190 (+1.233%)
15.600 +0.190 (+1.233%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.753 | 9.371 | 13.619 | 11.489 | 16.374 |
| 總資產報酬率 ROA (%) | 4.816 | 6.712 | 9.605 | 8.191 | 12.040 |
| 投入資產回報率 ROIC (%) | 6.348 | 8.619 | 12.357 | 10.279 | 14.937 | 邊際利潤分析 |
| 銷售毛利率 (%) | 57.682 | 61.449 | 69.590 | 66.064 | 68.737 |
| 營業利潤率 (%) | 29.835 | 31.503 | 39.282 | 31.536 | 38.240 |
| 息稅前利潤/營業總收入 (%) | 28.756 | 30.411 | 38.862 | 31.836 | 38.277 |
| 淨利潤/營業總收入 (%) | 24.496 | 26.385 | 32.979 | 27.620 | 32.778 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 91.784 | 93.696 | 92.262 | 98.279 | 101.940 |
| 價值變動淨收益/利潤總額(%) | 10.574 | 12.734 | 10.088 | 10.085 | 5.936 |
| 營業外收支淨額/利潤總額(%) | -3.670 | -3.061 | -0.999 | 0.273 | -0.484 | 償債能力分析 |
| 流動比率 (X) | 3.434 | 4.074 | 3.613 | 3.760 | 3.093 |
| 速動比率 (X) | 2.652 | 3.215 | 2.965 | 3.086 | 2.480 |
| 資產負債率 (%) | 18.551 | 15.103 | 16.669 | 17.180 | 21.437 |
| 帶息債務/全部投入資本 (%) | 3.606 | 6.703 | 7.714 | 9.313 | 10.398 |
| 股東權益/帶息債務 (%) | 2,651.525 | 1,379.922 | 1,185.620 | 965.910 | 854.724 |
| 股東權益/負債合計 (%) | 376.830 | 481.433 | 423.133 | 410.537 | 337.093 |
| 利息保障倍數 (X) | -1,241.479 | -194.623 | -1,241.805 | 148.579 | 173.116 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 150.146 | 168.280 | 152.549 | 161.858 | 145.412 |
| 存貨周轉天數 (天) | 407.571 | 394.727 | 345.746 | 329.435 | 328.805 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 25/11/2025 14:23 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
